CA
CASI Pharmaceuticals, Inc.
CASI · NASDAQ
$0.15 +3.08% (+$0.00)
Market Cap $2.25M
P/E Ratio -
Div. Yield -
ROE 358.32%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.08x
EV/FFO N/A
P/B N/A
Growth
78 /100
Growing Book val. growth 15.16%
Rev. growth 118.52%
FCF growth N/A
Profitability
16 /100
Weak Net margin 183.93%
Op. margin 167.98%
FCF margin 0.00%
Quality
44 /100
Average ROE 358.32%
ROA 201.86%
Asset turnover 1.10x
Debt
50 /100
Moderate Int. coverage -31.98x
Net debt/EBITDA -0.34x
Current ratio 0.30x
Stability
48 /100
Moderate Rev. volatility 116.31%
EPS volatility 25.29%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CASI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David A. Cory
Employees
233
Headquarters
Beijing